货号 | 8658T |
描述 | The Notch Receptor Interaction Antibody Sampler Kit provides an economical means to evaluate Notch signaling. The kit contains enough primary antibody to perform four western blots per primary. |
目标/特异性 | ADAM9 (D64B5) Rabbit mAb, DLL4 Antibody, Jagged1 (28H8) Rabbit mAb, Jagged2 (C23D2) Rabbit mAb, Numb (C29G11) Rabbit mAb, RBPSUH (D10A4) XP® Rabbit mAb, and TACE (D22H4) Rabbit mAb recognize endogenous levels of total respecitive protein. DLL1 Antibody recognizes only transfected levels of DLL1 protein. It does not recognize transfected levels of rat DLL3 or human DLL4. DLL3 (G93) Antibody recognizes only transfected levels of DLL3 protein. It does not recognize transfected levels of rat DLL1 or human DLL4. Jagged1 (28H8) Rabbit mAb does not cross-react with Jagged2. Jagged2 (C23D2) Rabbit mAb does not cross-react with Jagged1. |
供应商 | CST |
背景 | Notch signaling is activated upon engagement of the Notch receptor with its ligands, the Delta, Serrate, Lag2 (DSL) single-pass type I membrane proteins. DSL proteins contain multiple EGF-like repeats and a DSL domain that is required for binding to Notch (1,2). Five DSL proteins have been identified in mammals: Jagged1, Jagged2, Delta-like (DLL) 1, 3, and 4 (3). Ligand binding to the Notch receptor results in two sequential proteolytic cleavages of the receptor by the ADAM protease and the γ-secretase complex. The intracellular domain of Notch is released and then translocates to the nucleus where it activates transcription. Notch ligands may also be processed in a similiar manner, suggesting bi-directional signaling through receptor-ligand interactions (4-6).
TNF-α converting enzyme (TACE), also known as ADAM17, is a transmembrane metalloprotease that plays a key role in the cleavage of a number cell surface molecules in a process known as “shedding". TACE is abundantly expressed in many adult tissues, but in fetal development, expression is differentially regulated (7). TACE activates Notch in a ligand-independent manner and has been shown to play a role in the development of the Drosophila nervous system (8).
Recombining Binding Protein, SUppressor of Hairless (RBPSUH), also termed RBP-J or CSL, is the DNA-binding component of the transcription complex regulated by canonical Notch signaling. In the absence of Notch activation, RBPSUH suppresses target gene expression through interactions with a co-repressor complex containing histone deacetylase. Upon activation of Notch receptors, the Notch intracellular domain (NICD) translocates to the nucleus and binds to RBPSUH. This displaces the co-repressor complex and replaces it with a transcription activation complex that includes Mastermind-like (MAML) proteins and histone acetylase p300, leading to transcriptional activation of Notch target genes (9-11).
Numb contains an amino-terminal phosphotyrosine-binding (PTB) domain and carboxy-terminal endocytic binding motifs for α-adaptin and EH (Eps15 homology) domain-containing proteins, indicating a role in endocytosis (12,13). There are four mammalian Numb splicing isoforms that are differentially expressed and may have distinct functions (14-16). Numb acts as a negative regulator of Notch signaling by promoting ubiquitination and degradation of Notch (17). The protein is asymmetrically segregated into one daughter cell during cell division, producing two daughter cells with different responses to Notch signaling and different cell fates (18,19).Application References |
存放说明 | -20C |
参考文献 | 1 . Wilson, A. and Radtke, F. (2006) FEBS Lett. 580, 2860-2868. 2 . Black, R.A. et al. (1997) Nature 385, 729-33. 3 . Berdnik, D. et al. (2002) Dev. Cell 3, 221-231. 4 . Hansson, E.M. et al. (2004) Semin. Cancer Biol. 14, 320-328. 5 . Santolini, E. et al. (2000) J. Cell Biol. 151, 1345-1352. 6 . Chiba, S. (2006) Stem Cells 24, 2437-2447. 7 . Dho, S.E. et al. (1999) J. Biol. Chem. 274, 33097-33104. 8 . Bland, C.E. et al. (2003) J. Biol. Chem. 278, 13607-13610. 9 . Verdi, J.M. et al. (1999) Proc. Natl. Acad. Sci. USA 96, 10472-10476. 10 . Verdi, J.M. et al. (1999) Proc. Natl. Acad. Sci. USA 96, 10472-10476. 11 . Six, E. et al. (2003) Proc. Natl. Acad. Sci. USA 100, 7638-7643. 12 . Delwig, A. and Rand, M.D. (2008) Cell Mol Life Sci 65, 2232-43. 13 . LaVoie, M.J. and Selkoe, D.J. (2003) J. Biol. Chem. 278, 34427-34437. 14 . McGill, M.A. and McGlade, C.J. (2003) J. Biol. Chem. 278, 23196-23203. 15 . Verdi, J.M. et al. (1996) Curr. Biol. 6, 1134-1145. 16 . Reugels, A.M. et al. (2006) Dev. Dyn. 235, 934-948. 17 . Ehebauer, M. et al. (2006) Sci STKE 2006, cm7. 18 . Borggrefe, T. and Oswald, F. (2009) Cell Mol Life Sci 66, 1631-46. 19 . Kopan, R. and Ilagan, M.X. (2009) Cell 137, 216-33. |
Immunohistochemical analysis of paraffin-embedded human colon carcinoma using RBPSUH (D10A4) XP® Rabbit mAb. | |
Immunohistochemical analysis of paraffin-embedded human lung carcinoma using RBPSUH (D10A4) XP® Rabbit mAb in the presence of control peptide (left) or antigen-specific peptide (right). | |
Immunohistochemical analysis of paraffin-embedded human lung carcinoma using RBPSUH (D10A4) XP® Rabbit mAb. | |
Immunohistochemical analysis of paraffin-embedded E18.5 mouse lung, Rbpjk F/+Shh+/+ (wild type, left) or Rbpjk F/-Shhcre/+ (Rbpjk conditional knock out, right), using RBPSUH (D10A4) XP® Rabbit mAb. Note lack of staining in the bronchial epithelial cells in the conditional knock out tissue (right). Tissue courtesy of Dr. Wellington Cardosa, Boston University School of Medicine. | |
Immunohistochemical analysis of paraffin-embedded mouse lymph node using RBPSUH (D10A4) XP® Rabbit mAb. | |
Western blot analysis of extracts from various cell lines using RBPSUH (D10A4) XP® Rabbit mAb #5313. | |
Western blot analysis of extracts from various cell lines using Numb (C29G11) Rabbit mAb #2756. | |
Western blot analysis of extracts from Raji and Jurkat cells, untreated (-) or treated with peptide N-glycosidase F (PNGase F; +), using TACE (D22H4) Rabbit mAb #6978. | |
Western blot analysis of extracts from various cell lines using ADAM9 (D64B5) Rabbit mAb #4151. | |
Western blot analysis of extracts from HUVEC and COS cells, untransfected or transiently transfected with a construct expressing human DLL4, using DLL4 Antibody #2589. | |
Western blot analysis of extracts from COS cells, untransfected or transiently transfected with a construct expressing rat DLL1 protein, using DLL1 Antibody #2588. | |
Western blot analysis of extracts from COS cells, untransfected or transiently transfected with a construct expressing rat DLL3 protein, using DLL3 (G93) Antibody #2483. | |
Western blot analysis of extracts from various cell lines using Jagged2 (C23D2) Rabbit mAb #2210. | |
Western blot analysis of extracts from HepG2 and LNCaP cells using Jagged1 (28H8) Rabbit mAb #2620. | |
Western blot analysis of extracts from various cell lines using RBPSUH (D10A4) XP®Rabbit mAb. |